Échos Santé fête ses 10 ans : 2016-2026, une décennie d’information santé. Merci de nous lire !

L’information santé, au plus près de vousDécouvrir le média ↗
échosanté.COMPRENDRE · PRÉVENIR · MIEUX VIVREÉchos Santé a 10 ans
Accueil / A LA UNE / Lecture
A LA UNE3 MIN DE LECTURE

Fight Against HIV/AIDS and Malaria – The United States Offers Cameroon Nearly FCFA54 Billion to Cameroon

ÉS
Échos SantéPublié le · Échos Santé
19 px

Cameroon will benefit from financial support of nearly FCFA54 billion from the government of the United States of America. This is following a partnership agreement signed on June 1, 2021 between Yaoundé and Washington.

Ingrid KENGNE

This money will be used to strengthen the fight against AIDS and malaria, two pathologies that are wreaking havoc in Cameroon. To support the fight against these two diseases, Yaoundé, through the Minister of Finance, Louis Paul Motaze, signed on Tuesday June 1 in Yaoundé, a partnership agreement with Washington, represented by Vernelle Trim Fitz patrick, the official in charge of Affairs at the American Embassy in Cameroon. « We have plans to invest more than $100 million in two important projects; An AIDS control project and another malaria control project. These are two programs that represent a large part of the American investment in the health sector to help the Cameroonian people,”the American diplomat said after signing the contract.

The diplomatic representative of the United States in Yaoundé published a message on its digital platform on May 30 stating that, “The @ PEPFAR program (Cameroon National HIV Program) is the largest American investment in Cameroon, with nearly $54billion last year. It continues to strengthen global health security efforts, improve response and resilience to pandemics, and build sustainable health care infrastructure and capacity”.

In 2020, the U.S. Embassy congratulated the government of Cameroon on its decision to eliminate user fees for all HIV services at public health facilities and accredited community sites. Eliminating user fees would help Cameroon reach epidemic control of HIV.

It also reflects the cooperation of the Cameroonian and U.S. governments and other HIV stakeholders.  As a result of this historic commitment by the government of Cameroon, the United States was said to have tripled its assistance to Cameroon’s HIV program to over $97 million for 2020 (approximately FCFA57 billion).

In 2019, according to official figures, 540,000 people were living with HIV, with a percentage of 3.6% among adults (between 15 and 49 years). In 2020, 4, 121 people died from malaria in Cameroon.

As of July 2019, only 58% of them – a little over 304,000 people were on antiretroviral treatment.  With the elimination of HIV user fees, the financial barrier to treatment has been removed and significantly more People are being able to get tested, follow treatment and stay virally suppressed.

The U.S. Government, through PEPFAR, had been proud to partner with the Government and the people of Cameroon in accelerating progress.  Speaking during a special CRTV program for World AIDS Day in early December 2019, Ambassador Barlerin noted that the battle was not yet won, but that it is winnable. 

In 2020, PEPFAR’s support to Cameroon included provision of antiretroviral treatment, testing for HIV, and providing care and support for orphans, vulnerable children, and their caregivers.  The U.S. government continues its commitment to supporting Cameroon to end HIV/AIDS and malaria as a public health threat by 2030.

Notre rédaction vérifie chaque signalement.

AIDEZ-NOUS À RESTER EXACTS

Signaler une erreur

Cette lecture vous a-t-elle été utile ?

VOTRE VOIX COMPTE

La discussion. 15

Ouvrez la conversation. Quel est votre regard sur ce sujet ?

Les commentaires sont fermés.

L’INFO CONTINUE

Encore un peu
de perspective.

Fight Against HIV/AIDS and Malaria – The United States Offers Cameroon Nearly FCFA54 Billion to Cameroon

Fight Against HIV/AIDS and Malaria – The United States Offers Cameroon Nearly FCFA54 Billion to Cameroon

EXPLORER ÉCHOS SANTÉ

Que recherchez-vous ?

Rubriques

La lettre santé

Echos Santé

Connexion